KINDLER JEFFREY B — SEC Form 4 filings
SEC reporting owner CIK 1174454. 19 Form 4 filings on record with FilingPulse; latest filed 2026-08-28.
Transaction summary — filings shown
Covers all 19 filings on record, filed 2024-03-12 to 2026-08-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 4 filings — 612,425 shares, $3,333,986 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 42.
- Largest priced transaction: sale of 185,000 shares @ $7.44 ($1,376,400) in PRECIGEN, INC., filed 2026-08-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PRECIGEN, INC. (PGEN) | Director | 8 | — | 4 legs · 594,827 sh · $2,836,491 | 15 |
| PERRIGO Co plc (PRGO) | Director | 3 | — | 1 leg · 17,598 sh · $497,495 | 8 |
| Terns Pharmaceuticals, Inc. (TERN) | Director | 6 | — | — | 14 |
| Praxis Precision Medicines, Inc. (PRAX) | Director | 2 | — | — | 5 |
Form 4 filings — KINDLER JEFFREY B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-28 | 4 | PRECIGEN, INC. (PGEN) | Sale (S): 185,000 @ $7.44 | EDGAR |
| 2026-06-12 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 1,371 @ $0 · Grant/award (A): 648 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Disposition to issuer (D): 32,000 (derivative) · Disposition to issuer (D): 45,000 (derivative) · Disposition to issuer (D): 10,657 (derivative) · Disposition to issuer (D): 4,676 (derivative) · Disposition to issuer (D): 32,000 (derivative) · Disposition to issuer (D): 28,475 (derivative) · +3 more | EDGAR |
| 2026-03-16 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 71,839 · Option exercise (M): 71,839 (derivative) @ $0 | EDGAR |
| 2026-03-12 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 19,658 @ $3.51 · Grant/award (A): 35,612 (derivative) @ $0 · Grant/award (A): 41,073 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 688 @ $0 · Grant/award (A): 478 @ $0 · Grant/award (A): 224 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 1,697 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | PRECIGEN, INC. (PGEN) | Sale (S): 235,467 @ $3.63 | EDGAR |
| 2025-10-01 | 4 | PRECIGEN, INC. (PGEN) | Sale (S): 67,523 @ $3.60 · Sale (S): 106,837 @ $3.38 | EDGAR |
| 2025-06-12 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2025-05-16 | 4 | PERRIGO Co plc (PRGO) | Option exercise (M): 9,904 @ $26.01 · Tax withholding (F): 4,754 @ $26.01 · Grant/award (A): 7,305 (derivative) · Option exercise (M): 9,904 (derivative) | EDGAR |
| 2025-03-17 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 39,655 @ $1.74 · Option exercise (M): 87,412 · Grant/award (A): 71,839 (derivative) @ $0 · Option exercise (M): 87,412 (derivative) @ $0 · Grant/award (A): 83,517 (derivative) @ $0 | EDGAR |
| 2025-02-03 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 10,657 (derivative) @ $0 | EDGAR |
| 2024-12-10 | 4 | PERRIGO Co plc (PRGO) | Sale (S): 17,598 @ $28.27 | EDGAR |
| 2024-07-02 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 4,676 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Terns Pharmaceuticals, Inc. (TERN) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | PERRIGO Co plc (PRGO) | Option exercise (M): 8,764 @ $30.22 · Tax withholding (F): 4,207 @ $30.22 · Grant/award (A): 9,904 (derivative) · Option exercise (M): 8,764 (derivative) | EDGAR |
| 2024-03-18 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 48,251 @ $1.43 · Grant/award (A): 87,412 (derivative) @ $0 · Grant/award (A): 101,626 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 106,837 · Option exercise (M): 106,837 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1174454 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →